Urolon clinical trial: 12-month interim data available

17 July 2018

The Urolon™ European Clinical Trial reaches another milestone; all patients have now completed their 12-month follow-up visit.

urolon, bioresorbable, clinical data, 12-month, safe, effective, urethral bulking agent

Interim data show Urolon™ as a safe and effective treatment option for females with mild to moderate stress urinary incontinence (SUI) who have attempted or failed pelvic floor muscle training (PFMT).